_id
6911b953ccc777a4e85d610a
Ticker
GANX
Name
Gain Therapeutics Inc
Exchange
NASDAQ
Address
4800 Montgomery Lane, Bethesda, MD, United States, 20814
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://gaintherapeutics.com
Description
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson's disease with or without a GBA1 mutation. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher's disease, lysosomal storage disorders, metabolic disorders, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.
Last Close
4.11
Volume
1418167
Current Price
4.14
Change
0.7299270072992544
Last Updated
2025-11-30T19:11:29.735Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-18T00:00:00.000Z
Market Cap
126843504
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.4286
Target Price
6.8
Strong Buy
3
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
22817
Gross Profit
-22817
Operating Expenses
4762960
Operating Income
-4785777
Interest Expense
-
Pretax Income
-4735085
Net Income
-5284373
Eps
-0.15099045489950014
Dividends Per Share
-
Shares Outstanding
36241000
Income Tax Expense
549288
EBITDA
-4712266
Operating Margin
-
Total Other Income Expense Net
50692
Cash
8807353
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
10517268
Property Plant Equipment
269994
Total Assets
10971680
Payables
1577151
Short Term Debt
115910
Long Term Debt
298797
Total Liabilities
5062250
Equity
5909430
Depreciation
22817
Change In Working Capital
-135749
Cash From Operations
-4926436
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
7032825
Net Change In Cash
2113056
PE
-
PB
24.51877226737604
ROE
-89.4227192808782
ROA
-48.1637543202135
FCF
-4926436
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
22817
Quarters > 0 > income Statement > gross Profit
-22817
Quarters > 0 > income Statement > operating Expenses
4762960
Quarters > 0 > income Statement > operating Income
-4785777
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4735085
Quarters > 0 > income Statement > net Income
-5284373
Quarters > 0 > income Statement > eps
-0.15099045489950014
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
34998060
Quarters > 0 > income Statement > income Tax Expense
549288
Quarters > 0 > income Statement > EBITDA
-4712266
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
50692
Quarters > 0 > balance Sheet > cash
8807353
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
10517268
Quarters > 0 > balance Sheet > property Plant Equipment
269994
Quarters > 0 > balance Sheet > total Assets
10971680
Quarters > 0 > balance Sheet > payables
1577151
Quarters > 0 > balance Sheet > short Term Debt
115910
Quarters > 0 > balance Sheet > long Term Debt
298797
Quarters > 0 > balance Sheet > total Liabilities
5062250
Quarters > 0 > balance Sheet > equity
5909430
Quarters > 0 > cash Flow > net Income
-5284373
Quarters > 0 > cash Flow > depreciation
22817
Quarters > 0 > cash Flow > change In Working Capital
-135749
Quarters > 0 > cash Flow > cash From Operations
-4926436
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
7032825
Quarters > 0 > cash Flow > net Change In Cash
2113056
Quarters > 0 > ratios > PE
-0.15099045489950014
Quarters > 0 > ratios > PB
24.51877226737604
Quarters > 0 > ratios > ROE
-89.4227192808782
Quarters > 0 > ratios > ROA
-48.1637543202135
Quarters > 0 > ratios > FCF
-4926436
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
2722297
Quarters > 1 > income Statement > gross Profit
-2722297
Quarters > 1 > income Statement > operating Expenses
2367229
Quarters > 1 > income Statement > operating Income
-5089526
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-5667882
Quarters > 1 > income Statement > net Income
-5809087
Quarters > 1 > income Statement > eps
-0.19145667143999331
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
30341523
Quarters > 1 > income Statement > income Tax Expense
141205
Quarters > 1 > income Statement > EBITDA
-5085269
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-578356
Quarters > 1 > balance Sheet > cash
6694136
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
317844
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
9306703
Quarters > 1 > balance Sheet > property Plant Equipment
329390
Quarters > 1 > balance Sheet > total Assets
9833980
Quarters > 1 > balance Sheet > payables
2713013
Quarters > 1 > balance Sheet > short Term Debt
262428
Quarters > 1 > balance Sheet > long Term Debt
325359
Quarters > 1 > balance Sheet > total Liabilities
6137930
Quarters > 1 > balance Sheet > equity
3696050
Quarters > 1 > cash Flow > net Income
-5809087
Quarters > 1 > cash Flow > depreciation
22328
Quarters > 1 > cash Flow > change In Working Capital
-507531
Quarters > 1 > cash Flow > cash From Operations
-5098982
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2466682
Quarters > 1 > cash Flow > net Change In Cash
-2372230
Quarters > 1 > ratios > PE
-0.19145667143999331
Quarters > 1 > ratios > PB
33.98598645039975
Quarters > 1 > ratios > ROE
-157.1701410965761
Quarters > 1 > ratios > ROA
-59.07157630989691
Quarters > 1 > ratios > FCF
-5098982
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
2223099
Quarters > 2 > income Statement > gross Profit
-2223099
Quarters > 2 > income Statement > operating Expenses
2146277
Quarters > 2 > income Statement > operating Income
-4369376
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4429549
Quarters > 2 > income Statement > net Income
-4530058
Quarters > 2 > income Statement > eps
-0.15792198523730716
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
28685417
Quarters > 2 > income Statement > income Tax Expense
100509
Quarters > 2 > income Statement > EBITDA
-4364369
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-60173
Quarters > 2 > balance Sheet > cash
9070102
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
886617
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
11151417
Quarters > 2 > balance Sheet > property Plant Equipment
281173
Quarters > 2 > balance Sheet > total Assets
11624064
Quarters > 2 > balance Sheet > payables
2151410
Quarters > 2 > balance Sheet > short Term Debt
261795
Quarters > 2 > balance Sheet > long Term Debt
314476
Quarters > 2 > balance Sheet > total Liabilities
5844353
Quarters > 2 > balance Sheet > equity
5779711
Quarters > 2 > cash Flow > net Income
-4530058
Quarters > 2 > cash Flow > depreciation
20660
Quarters > 2 > cash Flow > change In Working Capital
158776
Quarters > 2 > cash Flow > cash From Operations
-3821527
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
2397078
Quarters > 2 > cash Flow > net Change In Cash
-1314914
Quarters > 2 > ratios > PE
-0.15792198523730716
Quarters > 2 > ratios > PB
20.54732950834393
Quarters > 2 > ratios > ROE
-78.37862481359362
Quarters > 2 > ratios > ROA
-38.9713786847698
Quarters > 2 > ratios > FCF
-3821527
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
82242
Quarters > 3 > income Statement > cost Of Revenue
21307
Quarters > 3 > income Statement > gross Profit
-21307
Quarters > 3 > income Statement > operating Expenses
3309797
Quarters > 3 > income Statement > operating Income
-3331104
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3263489
Quarters > 3 > income Statement > net Income
-3768227
Quarters > 3 > income Statement > eps
-0.13888195995162717
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27132588
Quarters > 3 > income Statement > income Tax Expense
504738
Quarters > 3 > income Statement > EBITDA
-3242180
Quarters > 3 > income Statement > operating Margin
-4050.368424892391
Quarters > 3 > income Statement > total Other Income Expense Net
67615
Quarters > 3 > balance Sheet > cash
10385863
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
765763
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
11602478
Quarters > 3 > balance Sheet > property Plant Equipment
323334
Quarters > 3 > balance Sheet > total Assets
12123884
Quarters > 3 > balance Sheet > payables
946259
Quarters > 3 > balance Sheet > short Term Debt
271090
Quarters > 3 > balance Sheet > long Term Debt
328327
Quarters > 3 > balance Sheet > total Liabilities
4784310
Quarters > 3 > balance Sheet > equity
7339574
Quarters > 3 > cash Flow > net Income
-3768227
Quarters > 3 > cash Flow > depreciation
21307
Quarters > 3 > cash Flow > change In Working Capital
-621029
Quarters > 3 > cash Flow > cash From Operations
-3454636
Quarters > 3 > cash Flow > capital Expenditures
945
Quarters > 3 > cash Flow > cash From Investing
-43447
Quarters > 3 > cash Flow > cash From Financing
2312838
Quarters > 3 > cash Flow > net Change In Cash
-1665837
Quarters > 3 > ratios > PE
-0.13888195995162717
Quarters > 3 > ratios > PB
15.304555049107753
Quarters > 3 > ratios > ROE
-51.341222256223595
Quarters > 3 > ratios > ROA
-31.081021560417437
Quarters > 3 > ratios > FCF
-3455581
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-42.01722963935702
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
84071
Annuals > 0 > income Statement > gross Profit
-84071
Annuals > 0 > income Statement > operating Expenses
20350592
Annuals > 0 > income Statement > operating Income
-20350592
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-19874376
Annuals > 0 > income Statement > net Income
-20411191
Annuals > 0 > income Statement > eps
-0.8920423409129199
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
22881415
Annuals > 0 > income Statement > income Tax Expense
536815
Annuals > 0 > income Statement > EBITDA
-20266521
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
476216
Annuals > 0 > balance Sheet > cash
10385863
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
765763
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
11602478
Annuals > 0 > balance Sheet > property Plant Equipment
323334
Annuals > 0 > balance Sheet > total Assets
12123884
Annuals > 0 > balance Sheet > payables
946259
Annuals > 0 > balance Sheet > short Term Debt
271090
Annuals > 0 > balance Sheet > long Term Debt
328327
Annuals > 0 > balance Sheet > total Liabilities
4784310
Annuals > 0 > balance Sheet > equity
7339574
Annuals > 0 > cash Flow > net Income
-20411191
Annuals > 0 > cash Flow > depreciation
84071
Annuals > 0 > cash Flow > change In Working Capital
-1080389
Annuals > 0 > cash Flow > cash From Operations
-18873827
Annuals > 0 > cash Flow > capital Expenditures
22493
Annuals > 0 > cash Flow > cash From Investing
4977507
Annuals > 0 > cash Flow > cash From Financing
13012076
Annuals > 0 > cash Flow > net Change In Cash
-1411412
Annuals > 0 > ratios > PE
-0.8920423409129199
Annuals > 0 > ratios > PB
10.911389748233345
Annuals > 0 > ratios > ROE
-278.0977615322088
Annuals > 0 > ratios > ROA
-168.35521520991128
Annuals > 0 > ratios > FCF
-18896320
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
55180
Annuals > 1 > income Statement > cost Of Revenue
80382
Annuals > 1 > income Statement > gross Profit
55180
Annuals > 1 > income Statement > operating Expenses
22308313
Annuals > 1 > income Statement > operating Income
-22253133
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-22188245
Annuals > 1 > income Statement > net Income
-22267520
Annuals > 1 > income Statement > eps
-1.7113905301682122
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
13011361
Annuals > 1 > income Statement > income Tax Expense
79275
Annuals > 1 > income Statement > EBITDA
-22169554
Annuals > 1 > income Statement > operating Margin
-40328.25842696629
Annuals > 1 > income Statement > total Other Income Expense Net
64888
Annuals > 1 > balance Sheet > cash
11794949
Annuals > 1 > balance Sheet > short Term Investments
4999704
Annuals > 1 > balance Sheet > receivables
242577
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
17778868
Annuals > 1 > balance Sheet > property Plant Equipment
585177
Annuals > 1 > balance Sheet > total Assets
18609331
Annuals > 1 > balance Sheet > payables
1318965
Annuals > 1 > balance Sheet > short Term Debt
348490
Annuals > 1 > balance Sheet > long Term Debt
449053
Annuals > 1 > balance Sheet > total Liabilities
6031107
Annuals > 1 > balance Sheet > equity
12578224
Annuals > 1 > cash Flow > net Income
-22267520
Annuals > 1 > cash Flow > depreciation
83579
Annuals > 1 > cash Flow > change In Working Capital
442230
Annuals > 1 > cash Flow > cash From Operations
-18865873
Annuals > 1 > cash Flow > capital Expenditures
15358
Annuals > 1 > cash Flow > cash From Investing
10222667
Annuals > 1 > cash Flow > cash From Financing
12641343
Annuals > 1 > cash Flow > net Change In Cash
4486541
Annuals > 1 > ratios > PE
-1.7113905301682122
Annuals > 1 > ratios > PB
3.6205241296386514
Annuals > 1 > ratios > ROE
-177.03230599168847
Annuals > 1 > ratios > ROA
-119.65782112210266
Annuals > 1 > ratios > FCF
-18881231
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-342.17526277636824
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
132640
Annuals > 2 > income Statement > cost Of Revenue
8243080
Annuals > 2 > income Statement > gross Profit
-8110440
Annuals > 2 > income Statement > operating Expenses
9666605
Annuals > 2 > income Statement > operating Income
-17777045
Annuals > 2 > income Statement > interest Expense
247377
Annuals > 2 > income Statement > pretax Income
-17497762
Annuals > 2 > income Statement > net Income
-17590738
Annuals > 2 > income Statement > eps
-1.480282189359111
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11883368
Annuals > 2 > income Statement > income Tax Expense
92976
Annuals > 2 > income Statement > EBITDA
-17760628
Annuals > 2 > income Statement > operating Margin
-13402.476628468034
Annuals > 2 > income Statement > total Other Income Expense Net
279283
Annuals > 2 > balance Sheet > cash
7311611
Annuals > 2 > balance Sheet > short Term Investments
12826954
Annuals > 2 > balance Sheet > receivables
103877
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
21091296
Annuals > 2 > balance Sheet > property Plant Equipment
804312
Annuals > 2 > balance Sheet > total Assets
24099387
Annuals > 2 > balance Sheet > payables
1626100
Annuals > 2 > balance Sheet > short Term Debt
337215
Annuals > 2 > balance Sheet > long Term Debt
495258
Annuals > 2 > balance Sheet > total Liabilities
5219873
Annuals > 2 > balance Sheet > equity
18879514
Annuals > 2 > cash Flow > net Income
-17590738
Annuals > 2 > cash Flow > depreciation
64168
Annuals > 2 > cash Flow > change In Working Capital
1514858
Annuals > 2 > cash Flow > cash From Operations
-14692139
Annuals > 2 > cash Flow > capital Expenditures
118953
Annuals > 2 > cash Flow > cash From Investing
-14774813
Annuals > 2 > cash Flow > cash From Financing
-78774
Annuals > 2 > cash Flow > net Change In Cash
-29569523
Annuals > 2 > ratios > PE
-1.480282189359111
Annuals > 2 > ratios > PB
2.2030115817599967
Annuals > 2 > ratios > ROE
-93.17368021231903
Annuals > 2 > ratios > ROA
-72.99247072135071
Annuals > 2 > ratios > FCF
-14811092
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-111.6638419782871
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
133928
Annuals > 3 > income Statement > cost Of Revenue
7164229
Annuals > 3 > income Statement > gross Profit
-7030301
Annuals > 3 > income Statement > operating Expenses
6795872
Annuals > 3 > income Statement > operating Income
-13826173
Annuals > 3 > income Statement > interest Expense
117861
Annuals > 3 > income Statement > pretax Income
-13886598
Annuals > 3 > income Statement > net Income
-13890606
Annuals > 3 > income Statement > eps
-1.3664588244599034
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
10165404
Annuals > 3 > income Statement > income Tax Expense
4008
Annuals > 3 > income Statement > EBITDA
-13822026
Annuals > 3 > income Statement > operating Margin
-10323.586553969297
Annuals > 3 > income Statement > total Other Income Expense Net
-60425
Annuals > 3 > balance Sheet > cash
36880673
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
195448
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
37722044
Annuals > 3 > balance Sheet > property Plant Equipment
1007028
Annuals > 3 > balance Sheet > total Assets
38985071
Annuals > 3 > balance Sheet > payables
560479
Annuals > 3 > balance Sheet > short Term Debt
322963
Annuals > 3 > balance Sheet > long Term Debt
590468
Annuals > 3 > balance Sheet > total Liabilities
4167525
Annuals > 3 > balance Sheet > equity
34817546
Annuals > 3 > cash Flow > net Income
-13890606
Annuals > 3 > cash Flow > depreciation
15484
Annuals > 3 > cash Flow > change In Working Capital
-329784
Annuals > 3 > cash Flow > cash From Operations
-12365670
Annuals > 3 > cash Flow > capital Expenditures
94212
Annuals > 3 > cash Flow > cash From Investing
-94212
Annuals > 3 > cash Flow > cash From Financing
41766775
Annuals > 3 > cash Flow > net Change In Cash
29407671
Annuals > 3 > ratios > PE
-1.3664588244599034
Annuals > 3 > ratios > PB
1.021867365379513
Annuals > 3 > ratios > ROE
-39.89541939572651
Annuals > 3 > ratios > ROA
-35.630577663947314
Annuals > 3 > ratios > FCF
-12459882
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-93.03418254584552
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.15099045489950014
Valuation > metrics > PB
24.51877226737604
Valuation > final Score
20
Valuation > verdict
717.3% Overvalued
Profitability > metrics > ROE
-89.4227192808782
Profitability > metrics > ROA
-50.24473085595993
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8566393036214999
Risk > metrics > Interest Coverage
-209.7277268942548
Risk > final Score
-791
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.211984092717274
Liquidity > metrics > Quick Ratio
6.211984092717274
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-5
Prev Risks > 1
-238
Prev Risks > 2
-577
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:31:39.944Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.15
Earnings History > 0 > eps Estimate
-0.15
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
0
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.19
Earnings History > 1 > eps Estimate
-0.17
Earnings History > 1 > eps Difference
-0.02
Earnings History > 1 > surprise Percent
-11.7647
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.16
Earnings History > 2 > eps Estimate
-0.18
Earnings History > 2 > eps Difference
0.02
Earnings History > 2 > surprise Percent
11.1111
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.08
Earnings History > 3 > eps Estimate
-0.1875
Earnings History > 3 > eps Difference
0.1075
Earnings History > 3 > surprise Percent
57.3333
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.17
Earnings History > 4 > eps Estimate
-0.21
Earnings History > 4 > eps Difference
0.04
Earnings History > 4 > surprise Percent
19.0476
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.42
Earnings History > 5 > eps Estimate
-0.2
Earnings History > 5 > eps Difference
-0.22
Earnings History > 5 > surprise Percent
-110
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.22
Earnings History > 6 > eps Estimate
-0.29
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
24.1379
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.36
Earnings History > 7 > eps Estimate
-0.32
Earnings History > 7 > eps Difference
-0.04
Earnings History > 7 > surprise Percent
-12.5
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.37
Earnings History > 8 > eps Estimate
-0.45
Earnings History > 8 > eps Difference
0.08
Earnings History > 8 > surprise Percent
17.7778
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.62
Earnings History > 9 > eps Estimate
-0.31
Earnings History > 9 > eps Difference
-0.31
Earnings History > 9 > surprise Percent
-100
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.43
Earnings History > 10 > eps Estimate
-0.39
Earnings History > 10 > eps Difference
-0.04
Earnings History > 10 > surprise Percent
-10.2564
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.39
Earnings History > 11 > eps Estimate
-0.38
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-2.6316
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.38
Earnings History > 12 > eps Estimate
-0.46
Earnings History > 12 > eps Difference
0.08
Earnings History > 12 > surprise Percent
17.3913
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.43
Earnings History > 13 > eps Estimate
-0.31
Earnings History > 13 > eps Difference
-0.12
Earnings History > 13 > surprise Percent
-38.7097
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.28
Earnings History > 14 > eps Estimate
-0.37
Earnings History > 14 > eps Difference
0.09
Earnings History > 14 > surprise Percent
24.3243
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.32
Earnings History > 15 > eps Estimate
-0.49
Earnings History > 15 > eps Difference
0.17
Earnings History > 15 > surprise Percent
34.6939
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.39
Earnings History > 16 > eps Estimate
-0.36
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-8.3333
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-11
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.3
Earnings History > 17 > eps Estimate
-0.3
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-10
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.5
Earnings History > 18 > eps Estimate
-0.21
Earnings History > 18 > eps Difference
-0.29
Earnings History > 18 > surprise Percent
-138.0952
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-22
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.4105
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.4105
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-09-30
Earnings History > 21 > report Date
2019-12-31
Earnings History > 21 > date
2019-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.3154
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.3154
Earnings History > 21 > surprise Percent
-
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson's disease with or without a GBA1 mutation. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher's disease, lysosomal storage disorders, metabolic disorders, and solid tumors. Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHere's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy Nasdaq
Read more →Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Average Rating of “Moderate Buy” from Analysts Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6.8
Analyst Picks
Strong Buy
3
Buy
4
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 11.65% of the total shares of Gain Therapeutics Inc
1.
JONES FINANCIAL COMPANIES LLLP(1.8829%)
since
2025/06/30
2.
Vanguard Group Inc(1.4864%)
since
2025/06/30
3.
Vanguard Institutional Extnd Mkt Idx Tr(1.003%)
since
2025/07/31
4.
Geode Capital Management, LLC(0.808%)
since
2025/06/30
5.
Marshall Wace Asset Management Ltd(0.769%)
since
2025/06/30
6.
Gotham Asset Management, LLC(0.684%)
since
2025/06/30
7.
CAMBRIDGE Invest RESEARCH ADVISORS, INC.(0.4993%)
since
2025/06/30
8.
Citadel Advisors Llc(0.4501%)
since
2025/06/30
9.
Fidelity Extended Market Index(0.4249%)
since
2025/07/31
10.
BANOR SICAV Rosemary S EUR Acc(0.3382%)
since
2025/06/30
11.
BlackRock Inc(0.313%)
since
2025/06/30
12.
Northern Trust Corp(0.2786%)
since
2025/06/30
13.
Renaissance Technologies Corp(0.2615%)
since
2025/06/30
14.
Susquehanna International Group, LLP(0.2213%)
since
2025/06/30
15.
Morgan Stanley - Brokerage Accounts(0.2128%)
since
2025/06/30
16.
State Street Corp(0.1979%)
since
2025/06/30
17.
iShares Micro-Cap ETF(0.1755%)
since
2025/08/31
18.
Kovitz Investment Group Partners, LLC(0.1324%)
since
2025/06/30
19.
Dauntless Investment Group, LLC(0.128%)
since
2025/06/30
20.
Fidelity Total Market Index(0.1254%)
since
2025/07/31
21.
Fidelity Series Total Market Index(0.1073%)
since
2025/07/31
22.
Springbok Capital Management, LLC(0.0996%)
since
2025/06/30
23.
Spartan Extended Market Index Pool F(0.0994%)
since
2025/07/31
24.
Extended Equity Market Fund K(0.0986%)
since
2025/06/30
25.
UBS Group AG(0.0908%)
since
2025/06/30
26.
Bridgeway Capital Management, LLC(0.0835%)
since
2025/06/30
27.
Bridgeway Ultra-Small Company Market(0.0835%)
since
2025/06/30
28.
Northern Trust Extended Eq Market Idx(0.082%)
since
2025/06/30
29.
NT Ext Equity Mkt Idx Fd - L(0.082%)
since
2025/06/30
30.
NT Ext Equity Mkt Idx Fd - NL(0.0683%)
since
2025/06/30
31.
Virtu Financial LLC(0.0662%)
since
2025/06/30
32.
Benedict Financial Advisors, INC.(0.0626%)
since
2025/06/30
33.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.053%)
since
2025/06/30
34.
Spartan Total Market Index Pool G(0.0509%)
since
2025/07/31
35.
Fidelity Nasdaq Composite Index(0.028%)
since
2025/07/31
36.
Vanguard U.S. Eq Idx ÂŁ Acc(0.0265%)
since
2025/07/31
37.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0231%)
since
2025/06/30
38.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0195%)
since
2024/12/31
39.
1290 VT Micro Cap K(0.0162%)
since
2025/07/31
40.
Extended Equity Market Fund M(0.0124%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.15
EPS Estimate
-0.15
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.